EP2474521A1 — High purity degree 2-[4-(3- and 2-fluorobenzyloxy)benzylamino]propanamides for use as medicaments and pharmaceutical formulations containing them
Assigned to Newron Pharmaceuticals SpA · Expires 2012-07-11 · 14y expired
What this patent protects
High purity degree (S)-2-[4-(3- and 2-fluorobenzyloxy)-benzylamino]propanamides with a content of genotoxic dibenzyl derivatives impurities lower than 0.03%, preferably lower than 0.01%, by weight for use as safe medicaments and pharmaceutical composition containing them as the a…
USPTO Abstract
High purity degree (S)-2-[4-(3- and 2-fluorobenzyloxy)-benzylamino]propanamides with a content of genotoxic dibenzyl derivatives impurities lower than 0.03%, preferably lower than 0.01%, by weight for use as safe medicaments and pharmaceutical composition containing them as the active agents.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.